Paper39355646
Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study.
Naja K and 3 others. J Pharm Pharm Sci, 2024. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study. Papers, record 39355646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39355646
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacometabolomics of sulfonylureas in patients with type 2 diabetes: a cross-sectional study.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Sulfonylurea Compounds | Major topic |
| Hypoglycemic Agents | Major topic |
| Metabolomics | Major topic |
| Humans | |
| Cross-Sectional Studies | |
| Male | |
| Female | |
| Middle Aged | |
| Aged | |
| Glycated Hemoglobin |
Source PubMed
References58
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29305667 | A pilot study comparing the metabolic profiles of elite-level athletes from different sporting disciplines. | Sports Med Open | 2018 | https://conductscience.org/library/papers/29305667 | PubMed |
| 2 | 21186350 | Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. | Nat Genet | 2011 | https://conductscience.org/library/papers/21186350 | PubMed |
| 3 | 35727887 | Comprehensive Review of γ-Glutamyl Peptides (γ-GPs) and Their Effect on Inflammation Concerning Cardiovascular Health. | J Agric Food Chem | 2022 | https://conductscience.org/library/papers/35727887 | PubMed |
| 4 | 31536110 | Sulfonylureas and Cardiovascular Safety: The Final Verdict? | JAMA | 2019 | https://conductscience.org/library/papers/31536110 | PubMed |
| 5 | 36543979 | Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis. | Nat Cell Biol | 2023 | https://conductscience.org/library/papers/36543979 | PubMed |
| 6 | 33589583 | Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/33589583 | PubMed |
| 7 | 28611053 | The rs7903146 Variant in the TCF7L2 Gene Increases the Risk of Prediabetes/Type 2 Diabetes in Obese Adolescents by Impairing β-Cell Function and Hepatic Insulin Sensitivity. | Diabetes Care | 2017 | https://conductscience.org/library/papers/28611053 | PubMed |
| 8 | 32572055 | Urine 6-Bromotryptophan: Associations with Genetic Variants and Incident End-Stage Kidney Disease. | Sci Rep | 2020 | https://conductscience.org/library/papers/32572055 | PubMed |
| 9 | 32059521 | Arachidonoylcholine and Other Unsaturated Long-Chain Acylcholines Are Endogenous Modulators of the Acetylcholine Signaling System. | Biomolecules | 2020 | https://conductscience.org/library/papers/32059521 | PubMed |
| 10 | 37429905 | The metabolomic profiling of total fat and fat distribution in a multi-cohort study of women and men. | Sci Rep | 2023 | https://conductscience.org/library/papers/37429905 | PubMed |
| 11 | 37626661 | Pharmacometabolomic Approach to Investigate the Response to Metformin in Patients with Type 2 Diabetes: A Cross-Sectional Study. | Biomedicines | 2023 | https://conductscience.org/library/papers/37626661 | PubMed |
| 12 | 26237395 | Roles of Sphingolipid Metabolism in Pancreatic β Cell Dysfunction Induced by Lipotoxicity. | J Clin Med | 2014 | https://conductscience.org/library/papers/26237395 | PubMed |
| 13 | 31958027 | Metabolomics in pharmacology - a delve into the novel field of pharmacometabolomics. | Expert Rev Clin Pharmacol | 2020 | https://conductscience.org/library/papers/31958027 | PubMed |
| 14 | 28380376 | SIRT4 Is a Lysine Deacylase that Controls Leucine Metabolism and Insulin Secretion. | Cell Metab | 2017 | https://conductscience.org/library/papers/28380376 | PubMed |
| 15 | 35053251 | Multi-Organ Crosstalk with Endocrine Pancreas: A Focus on How Gut Microbiota Shapes Pancreatic Beta-Cells. | Biomolecules | 2022 | https://conductscience.org/library/papers/35053251 | PubMed |
| 16 | 24563333 | Sulfonylureas: a new look at old therapy. | Curr Diab Rep | 2014 | https://conductscience.org/library/papers/24563333 | PubMed |
| 17 | 35185350 | Position of Sulfonylureas in the Current ERA: Review of National and International Guidelines. | Clin Med Insights Endocrinol Diabetes | 2022 | https://conductscience.org/library/papers/35185350 | PubMed |
| 18 | 15901787 | Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. | J Neurosci | 2005 | https://conductscience.org/library/papers/15901787 | PubMed |
| 19 | 21349175 | TCF7L2 and therapeutic response to sulfonylureas in patients with type 2 diabetes. | BMC Med Genet | 2011 | https://conductscience.org/library/papers/21349175 | PubMed |
| 20 | 24559921 | The calcium-sensing receptor and β-cell function. | Vitam Horm | 2014 | https://conductscience.org/library/papers/24559921 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978695 | Diabesity: an old term, a modern challenge - multi-omics and precision anti-obesity pharmacotherapy in type 2 diabetes. | J Pharm Pharm Sci | 2026 | https://conductscience.org/library/papers/42978695 | PubMed |
| 42882529 | Targeting Gut Microbiota, Inflammation, and Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: Therapeutic Strategies and the Emerging Role of Time-Restricted Feeding. | Cells | 2026 | https://conductscience.org/library/papers/42882529 | PubMed |
| 42346643 | Bridging Ancestry-Stratified Bias in Pharmacogenomics AI: Toward Metabolomics-Inclusive Multi-Omics Precision Medicine. | J Pers Med | 2026 | https://conductscience.org/library/papers/42346643 | PubMed |
| 41987878 | Pharmacological treatment patterns, factors associated with glycemic control, and renal function parameters in a real-world cohort of Hispanic adults with type 2 diabetes. | Biomed Rep | 2026 | https://conductscience.org/library/papers/41987878 | PubMed |
| 41900041 | Applications of Carbon Dots and Graphene Quantum Dots in Treatment of Diabetes. | Molecules | 2026 | https://conductscience.org/library/papers/41900041 | PubMed |
| 41872653 | Implications of Genetic Elements on Type 2 Diabetes Mellitus Pathogenesis and Management. | Endocrinol Diabetes Metab | 2026 | https://conductscience.org/library/papers/41872653 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39355646
GET https://conductscience.org/api/papers/v1/39355646/references?page=2